Nisa Investment Advisors LLC Acquires 830 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Nisa Investment Advisors LLC increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 115,363 shares of the medical device company’s stock after buying an additional 830 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Cooper Companies were worth $10,605,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Victory Capital Management Inc. increased its stake in shares of Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares during the last quarter. JPMorgan Chase & Co. increased its position in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after buying an additional 573,908 shares during the last quarter. International Assets Investment Management LLC bought a new stake in shares of Cooper Companies in the third quarter valued at $46,727,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Cooper Companies by 11.9% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock worth $200,665,000 after acquiring an additional 194,118 shares during the period. Finally, Soros Fund Management LLC bought a new stake in shares of Cooper Companies in the third quarter valued at approximately $19,310,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on COO shares. Wells Fargo & Company upped their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Citigroup lowered their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Morgan Stanley reduced their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Finally, StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Price Performance

Shares of COO stock opened at $95.68 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The firm has a market cap of $19.10 billion, a P/E ratio of 49.07, a P/E/G ratio of 2.42 and a beta of 0.99. The business’s 50 day moving average price is $95.99 and its 200-day moving average price is $99.14.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the previous year, the business posted $0.87 earnings per share. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.